Previous Close | 50.74 |
Open | 50.74 |
Bid | 59.40 |
Ask | 62.20 |
Strike | 140.00 |
Expire Date | 2024-12-20 |
Day's Range | 50.74 - 50.74 |
Contract Range | N/A |
Volume | |
Open Interest | 10 |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.